Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Jul 14, 2021 12:14pm
127 Views
Post# 33542591

RE:RE:Expect the SP to sink below $0.40 going forward.

RE:RE:Expect the SP to sink below $0.40 going forward.1.7-1.9M is better than decent but no one cares.

All it shows is a gradual decline in revenue from a high of Q4.

Even with all the other good looking possibilities why would anyone invest in something that is declining when there is no proof that aristotle will do anything.

What happened to gap boy?  Remember that thing calling for .35-.45 back when we were a buck.  Everyone thought he was just BS.  Looks like that piece of garbage was 100% correct and everyone else was wrong.  30s by the end of the week.

how much farther does this fall when the new shares are released?  

remember when we did the reverse split and half of the people said we would fall back to 8 cents just like most reverse splits and the other half said that was crazy? Looks like without life saving covid thats exactly what would had happened to this company.
<< Previous
Bullboard Posts
Next >>